Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013


Commercial Aspects of Drug Development

04 Apr 2013 - 05 Apr 2013 - Budapest, Hungary



Bookmark and Share


COURSE INTRODUCTION

This course is designed to provide more detail and build on the basic principles of business
transactions in clinical development.

The course is an intense two day programme which includes practical tools and in-depth analysis skills for Executives coming from the Pharma, Biotech and Contract Research Organizations. It is highly interactive and based around in-depth analysis of numerous case studies.

Unlike other courses that focus on a particular skill or aspect, this programme addresses all key steps in the transaction development process, equipping you with powerful decision-support tools, expert insight into key success factors and time-saving advice.

THROUGH THIS COURSE YOU WILL
Understand the process of deal-making within the pharmaceutical and biotech industries
Learn how to choose the right sales approach
Identify the key elements of the proposition
Grasp the principles of deal valuation and know what works best for which purpose
Get expert advice on negotiation strategy and tools, on how to best conduct the interactions
Know how to best manage the contract phase
Avoid financial and legal pitfalls that can break a deal
...and more.


Further information
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!